Washington University investigators at Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine in St. Louis have been awarded a $15 million grant to study genetic changes that drive acute myeloid leukemia and predict patients’ responses to therapy.
Urologic oncologist Wayne Brisbane thought his patient might be a good candidate for focal therapy.
